David Chi Leung Lam

514 total citations
41 papers, 345 citations indexed

About

David Chi Leung Lam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, David Chi Leung Lam has authored 41 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in David Chi Leung Lam's work include Lung Cancer Treatments and Mutations (13 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). David Chi Leung Lam is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). David Chi Leung Lam collaborates with scholars based in China, Hong Kong and United Kingdom. David Chi Leung Lam's co-authors include Msm Ip, Wang Chun Kwok, Terence Chi Chun Tam, Jcm Ho, King‐Pui Florence Chan, Pak‐Leung Ho, Stephanie Chow, Hong Zhu, Wei Cai and Vicky P.C. Tin and has published in prestigious journals such as International Journal of Pharmaceutics, Cancer Letters and Addiction.

In The Last Decade

David Chi Leung Lam

34 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chi Leung Lam China 10 152 73 67 45 39 41 345
Sherif Mohamed Egypt 12 182 1.2× 91 1.2× 72 1.1× 71 1.6× 32 0.8× 63 477
Jonathan C. Levin United States 13 162 1.1× 37 0.5× 142 2.1× 51 1.1× 13 0.3× 30 418
Jianguo Fu China 9 58 0.4× 57 0.8× 66 1.0× 16 0.4× 31 0.8× 15 265
Hangming Dong China 11 141 0.9× 25 0.3× 98 1.5× 47 1.0× 25 0.6× 30 435
Wenhui Huang China 9 43 0.3× 40 0.5× 107 1.6× 100 2.2× 77 2.0× 15 315
James Harper United States 11 73 0.5× 48 0.7× 50 0.7× 27 0.6× 15 0.4× 30 336
Fred B. Smith United States 11 156 1.0× 39 0.5× 82 1.2× 48 1.1× 20 0.5× 22 462
Chien-Liang Wu Taiwan 7 181 1.2× 219 3.0× 40 0.6× 15 0.3× 38 1.0× 9 484
Ankona Banerjee United States 12 149 1.0× 71 1.0× 109 1.6× 24 0.5× 10 0.3× 31 541

Countries citing papers authored by David Chi Leung Lam

Since Specialization
Citations

This map shows the geographic impact of David Chi Leung Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chi Leung Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chi Leung Lam more than expected).

Fields of papers citing papers by David Chi Leung Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chi Leung Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chi Leung Lam. The network helps show where David Chi Leung Lam may publish in the future.

Co-authorship network of co-authors of David Chi Leung Lam

This figure shows the co-authorship network connecting the top 25 collaborators of David Chi Leung Lam. A scholar is included among the top collaborators of David Chi Leung Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chi Leung Lam. David Chi Leung Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwok, Wang Chun, et al.. (2025). Asthma control after recovery from mild to moderate COVID-19: from Omicron BA.2 to XBB– from a cohort in a university hospital in Hong Kong. BMC Pulmonary Medicine. 25(1). 74–74. 2 indexed citations
2.
Kwok, Wang Chun, Desmond Y. H. Yap, Terence Chi Chun Tam, et al.. (2025). Impact of Hyponatraemia at Clinical Stable-State on Survival in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 20. 127–135.
3.
4.
Kwok, Wang Chun, Terence Chi Chun Tam, Jcm Ho, et al.. (2024). Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation. International Journal of COPD. Volume 19. 77–86. 4 indexed citations
5.
Kwok, Wang Chun, et al.. (2024). Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity. Journal of Thoracic Disease. 16(5). 2767–2775. 2 indexed citations
6.
Kwok, Wang Chun, Ting Fung, Jcm Ho, et al.. (2023). Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology. 28(7). 669–676. 3 indexed citations
7.
Sing, Chor‐Wing, Richard Hubbard, David Chi Leung Lam, et al.. (2023). Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study. The Lancet Regional Health - Western Pacific. 42. 100871–100871. 5 indexed citations
8.
Chow, Stephanie, et al.. (2023). Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: Design, optimization and therapeutic potential for respiratory viral infections. International Journal of Pharmaceutics. 644. 123303–123303. 17 indexed citations
9.
Kwok, Wang Chun, Terence Chi Chun Tam, David Chi Leung Lam, et al.. (2023). Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respiratory Research. 24(1). 53–53. 10 indexed citations
10.
Chan, Hok Sum, et al.. (2023). Hospital Burden of Chronic Obstructive Pulmonary Disease in Hong Kong – The Trend from 2006 to 2014. International Journal of COPD. Volume 18. 507–519. 4 indexed citations
11.
Hubbard, Richard, et al.. (2022). Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong. Pharmacoepidemiology and Drug Safety. 31(5). 519–523. 17 indexed citations
12.
Kwok, Wang Chun, Jcm Ho, Terence Chi Chun Tam, Msm Ip, & David Chi Leung Lam. (2022). Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use. Journal of Thoracic Disease. 14(6). 1880–1889. 3 indexed citations
13.
14.
Kwok, Wang Chun, Jcm Ho, Terence Chi Chun Tam, Msm Ip, & David Chi Leung Lam. (2021). Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respiratory Research. 22(1). 132–132. 26 indexed citations
15.
Chan, King‐Pui Florence, Ting Fung, Wang Chun Kwok, et al.. (2020). Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respiratory Medicine. 171. 106085–106085. 67 indexed citations
16.
17.
Kwok, Wang Chun, Jcm Ho, David Chi Leung Lam, et al.. (2019). When compared to plasma‐based detection, osimertinib‐treated non‐small cell lung cancer (NSCLC) with tissue rebiopsy‐confirmed acquired T790M mutation is associated with better survival. Asia-Pacific Journal of Clinical Oncology. 17(2). e35–e39. 2 indexed citations
18.
Chan, Hok Sum, Fanny W.S. Ko, Johnny Wai Man Chan, et al.. (2018). Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis. International Journal of COPD. Volume 13. 1913–1925. 4 indexed citations
19.
Kwok, Wang Chun, Terence Chi Chun Tam, & David Chi Leung Lam. (2018). First reported case of afatinib‐associated toxic megacolon. Respirology Case Reports. 6(7). e00360–e00360. 2 indexed citations
20.
Fung, Colman Siu Cheung, Esther Yee Tak Yu, Vivian Yawei Guo, et al.. (2016). Development of a Health Empowerment Programme to improve the health of working poor families: protocol for a prospective cohort study in Hong Kong. BMJ Open. 6(2). e010015–e010015. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherif Mohamed Breakdown of academic impact, for papers by Jonathan C. Levin Breakdown of academic impact, for papers by Jianguo Fu Breakdown of academic impact, for papers by Hangming Dong Breakdown of academic impact, for papers by Wenhui Huang Breakdown of academic impact, for papers by James Harper Breakdown of academic impact, for papers by Fred B. Smith Breakdown of academic impact, for papers by Chien-Liang Wu Breakdown of academic impact, for papers by Ankona Banerjee
Rankless by CCL
2026